This website is intended for healthcare professionals only.

Newsletter      
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Latest news

COVID-19 drug trial could lead to enhanced respiratory care for patients
Are smokers protected from COVID-19?

 

More news

IL-17 a potential therapeutic target in chronic urticaria
New insight of the causes of an allergic reaction raises hope for treatment
Children and COVID-19: is it safe to return to school?
Commentary: Cow’s milk allergy the most significant burden in children with multiple allergies
Are inhaled corticosteroids safe in those with COVID-19?
Loss of smell added to list of COVID-19 symptoms
Commentary: Increased risk of herpes zoster in patients prescribed JAK inhibitors
Link between IBD and coeliac disease established
Chronic kidney disease: COVID-19 rapid guideline summary
Which COVID-19 patients develop critical illness?
ONS infection survey suggests nearly 150,000 have COVID-19
Public Health England approves coronavirus antibody test


Popular articles

Is vitamin D an important biomarker for symptom severity in COVID-19?
NICE publishes first rapid COVID-19 guidelines
How to assess systemic lupus erythematosus in clinical care
Acute use of NSAIDs for people with or at risk of COVID-19: rapid evidence summary
Sponsored: The benefits of working with the global leader in diagnostics to support the diagnosis of allergic and autoimmune diseases




 
Hospital Healthcare Europe
 
LinkedIn Logo Footer  Twitter Logo Footer

Ⓒ Cogora 2020
Cogora Limited, 140 London Wall, London EC2Y 5DN, Registered in the United Kingdom. Reg. No. 2147432

Hospital Healthcare Europe
HOPE Logo Footer